Search

everythinglearnresearchcommunity

for

Search:↓

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Hair shaft miR-221 levels can help detect malignant melanoma.

The new nanoparticles could improve melanoma treatment by working better than current options.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

The AI model somewhat predicts lymph node status in melanoma patients using skin sample images.

People with myotonic dystrophy type 1 tend to develop basal cell carcinoma at a younger age but not more frequently than others.

A 12-year-old girl was misdiagnosed with alopecia areata but actually had a nevus sebaceus with a genetic mutation.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Notch/RBP-J signaling is crucial for proper placement and timing of melanocyte development in hair follicles.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Deleting TNFα gene reduces skin cancer risk in certain mice.

SPRY1 deficiency in skin cells causes stem cells to move to the skin surface, leading to increased pigmentation.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.